FDA clears first opioid withdrawal device

Providing another tool for clinicians to use in the opioid abuse crisis, FDA granted a new indication to a device that can help reduce the symptoms of withdrawal from the prescription pain drugs.

FDA granted the new indication to the NSS-2 Bridge device (Innovative Health Solutions), a small electrical nerve stimulator placed behind the patient’s ear. The device contains a battery-powered chip that emits electrical pulses to stimulate branches of certain cranial nerves, which may provide relief from opioid withdrawal symptoms, according to a statement from FDA.